Open Orphan's Cathal Friel on its £12mln raise to accelerate coronavirus antiviral testing

Published by : Proactive
Open Orphan PLC's (LON:ORPH) Cathal Friel speaks to Proactive London's Andrew Scott after announcing they've raised approximately £12mln to ramp up its coronavirus (COVID-19) antiviral testing.

Friel says the fundraise has brought many new leading blue-chip institutional shareholders to their share register.
cached video